Matteo Fallico Selected Research

Matteo Fallico Research Topics

Disease

9	Macular Edema 12/2023 - 01/2017
8	Retinal Detachment (Retinal Detachments) 12/2022 - 01/2018
6	Macular Degeneration (Age-Related Maculopathy) 05/2021 - 01/2017
5	Cataract (Cataracts) 12/2022 - 01/2018
5	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2021 - 01/2017
4	Retinal Perforations 01/2023 - 01/2018
4	Epiretinal Membrane (Epiretinal Membranes) 01/2021 - 01/2018
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
2	COVID-19 01/2024 - 01/2021
2	Glaucoma 09/2022 - 01/2021
2	Pneumonia (Pneumonitis) 01/2021 - 08/2020
2	Retinal Telangiectasis 01/2020 - 01/2017
1	Vascular Diseases (Vascular Disease) 01/2024
1	Inflammation (Inflammations) 01/2024
1	Central Serous Chorioretinopathy 12/2023
1	Blepharitis 07/2023
1	Dry Eye Syndromes (Dry Eye Syndrome) 07/2023
1	Keratitis 07/2023
1	Conjunctivitis 07/2023
1	Atopic Dermatitis (Atopic Eczema) 07/2023
1	Acanthamoeba Keratitis 09/2022
1	Cysts 01/2022
1	Choroidal Neovascularization 01/2022
1	Intraoperative Complications 12/2021
1	Stroke (Strokes) 12/2021
1	Eye Infections 05/2021
1	Pseudophakia 05/2021
1	Uveal melanoma 05/2021
1	Neoplasms (Cancer) 01/2021
1	Ganglion Cysts (Ganglion) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Thrombotic Microangiopathies 01/2021
1	Retinal Diseases 01/2020
1	Disease Progression 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Vitreous Hemorrhage 11/2019
1	Ocular Hypertension (Glaucoma, Suspect) 11/2019
1	Nausea 03/2019
1	Hemorrhage 03/2019
1	Vomiting 03/2019
1	Postoperative Nausea and Vomiting (PONV) 03/2019
1	Uveitis 01/2017
1	Retinal Vein Occlusion 01/2017
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2017
1	Telangiectasis (Telangiectasia) 01/2017
1	Retinal Neoplasms 01/2017
1	Kearns-Sayre Syndrome 01/2015
1	Blepharoptosis (Ptosis, Eyelid) 01/2015

Drug/Important Bio-Agent (IBA)

8	Retinaldehyde (Retinal)IBA 01/2024 - 01/2017
7	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023 - 01/2017
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 11/2019
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2019
2	afliberceptIBA 12/2020 - 07/2019
2	Insulin-Like PeptidesIBA 02/2019 - 12/2018
1	brolucizumabIBA 12/2023
1	dupilumabIBA 07/2023
1	SiliconIBA 01/2023
1	polihexanideIBA 09/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	Vascular Endothelial Growth FactorsIBA 09/2021
1	CoagulaseIBA 05/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2021
1	Methicillin (Metin)FDA Link 05/2021
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2020
1	CytokinesIBA 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2020
1	Ranibizumab (Lucentis)FDA Link 01/2020
1	Ruthenium-106IBA 07/2019
1	RutheniumIBA 07/2019
1	Ondansetron (Zofran)FDA LinkGeneric 03/2019
1	AntiemeticsIBA 03/2019
1	Sirtuin 1IBA 02/2019
1	Insulin (Novolin)FDA Link 12/2018
1	SuspensionsIBA 01/2015

Therapy/Procedure

17	Vitrectomy 01/2023 - 01/2017
10	Therapeutics 07/2023 - 01/2019
4	Lasers (Laser) 01/2023 - 01/2018
4	Scleral Buckling 12/2022 - 01/2017
3	Injections 01/2022 - 07/2019
3	Radiotherapy 05/2021 - 07/2019
2	Light Coagulation 09/2021 - 01/2018
1	Contact Lenses 09/2022
1	Filtering Surgery 09/2022
1	Aftercare (After-Treatment) 01/2022
1	Critical Care (Surgical Intensive Care) 08/2020
1	Intravitreal Injections 01/2020
1	Brachytherapy 07/2019
1	Local Anesthesia 03/2019
1	Vitreoretinal Surgery 03/2019
1	Traction 01/2018